Kayne Anderson Rudnick Investment Management LLC Eli Lilly & CO Transaction History

Kayne Anderson Rudnick Investment Management LLC

$43.7 Billion
Q3 2024

A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 84,735 shares of LLY stock, worth $65.1 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

84,735

Previous 85,962 1.43%

Holding current value

$65.1 Million

Previous $77.8 Million 3.54%

% of portfolio

0.17%

Previous 0.2%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $947,415 - $1.18 Million	-1,227 Reduced 1.43%	84,735 $75.1 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $2.51 Million - $3.15 Million	-3,466 Reduced 3.88%	85,962 $77.8 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $1.14 Million - $1.52 Million	-1,921 Reduced 2.1%	89,428 $69.6 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $1.48 Million - $1.74 Million	-2,809 Reduced 2.98%	91,349 $53.2 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $1.37 Million - $1.88 Million	-3,141 Reduced 3.23%	94,158 $50.6 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $11.1 Million - $14.9 Million	31,671 Added 48.26%	97,299 $45.6 Million
Q1 2023 May 16, 2023	SELL	$310.63 - $364.82 $621,881 - $730,369	-2,002 Reduced 2.96%	65,628 $22.5 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $11.4 Million - $13.3 Million	35,587 Added 111.06%	67,630 $24.7 Million
Q3 2022 Nov 16, 2022	BUY	$296.48 - $337.87 $9.5 Million - $10.8 Million	32,043 New	32,043 $10.4 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $641,582 - $731,150	-2,164 Closed	0 $10.4 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $34,005 - $39,926	-122 Reduced 5.34%	2,164 $702,000
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $76,978 - $95,664	328 Added 16.75%	2,286 $655,000
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $2,473 - $3,069	11 Added 0.56%	1,958 $541,000
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $12,188 - $14,999	55 Added 2.91%	1,947 $450,000
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $36,110 - $46,708	-200 Reduced 9.56%	1,892 $434,000
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $205,585 - $237,796	1,406 Added 204.96%	2,092 $310,000
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $27,283 - $32,836	200 Added 41.15%	686 $113,000
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $53,843 - $62,849	486 New	486 $54,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Account

Kayne Anderson Rudnick Investment Management LLC Eli Lilly & CO Transaction History